RxDoctor Payments Data

Alexis Hill, DO

Internal Medicine · Lisbon, OHNPI 1356847610

Payments from drug & device makers

$1,272in general payments, 2019–2025

Across 76 payments — averaging $16.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$196
  • Novo Nordisk$192
  • AstraZeneca$184
  • GSK$131
  • Lilly USA, LLC$108
  • Bayer$90
  • plus $371 from 15 others

What the payments were for

  • Food & beverage$1,272100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,272 in reported general payments places this provider in the 75th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$45,633
Medicare patients
127
Services billed
650

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide80$82,605
JardianceEmpagliflozin44$54,996
EliquisApixaban59$52,946
Trelegy ElliptaFluticasone/Umeclidin/Vilanter49$40,707
TrulicityDulaglutide32$37,472
XareltoRivaroxaban12$16,126
MounjaroTirzepatide15$15,987
VascepaIcosapent Ethyl15$11,770
Rosuvastatin Calcium140$3,932
ShingrixVaricella-Zoster Ge/As01b/Pf15$3,252
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$2,324
Ezetimibe49$2,175
Atorvastatin Calcium220$2,039
Metoprolol Succinate114$1,554
Omeprazole115$1,451

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$192$82,60580 claims
Boehringer IngelheimJardiance$15$54,99644 claims
Lilly USA, LLCTrulicity, Mounjaro$108$53,45947 claims
PfizerEliquis$196$52,94659 claims
GSKTrelegy Ellipta, Shingrix$131$43,95964 claims
Johnson & JohnsonXarelto$16$16,12612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Lisbon

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →